You are here

China Resilience Initiative

Primary tabs

Group description: 
This Working Group is focused on developing a China Resilience Initiative to ensure resilience and sustainability for citizens of China.
Group roles and permissions: 
Use default roles and permissions
Group visibility: 
Public - accessible to all site users

Members

admin Albert Gomez ChrisAllen efrost Kathy Gilbeaux Maeryn Obley
QuentinEichbaum

Email address for group

China orders 51 million into lockdown as COVID surges in major outbreak

 

China placed all 17 million residents in one of its biggest cities under lockdown on Sunday, as virus cases doubled nationwide to nearly 3,400 and anxiety mounted over the resilience of its 'zero-Covid' approach in the face of the worst outbreak in two years.

The southern tech hub of Shenzhen told all residents to stay at home as the city struggles to eradicate an Omicron flare-up linked to neighbouring virus-ravaged Hong Kong. ...

The surge in infections across China has also prompted authorities to close schools in Shanghai and lock down multiple northeastern cities, as 18 provinces battle clusters of the Omicron and Delta variants. ...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Overview: Asia developments, Hong Kong, South Korea, China vaccine situation

Feb 28 (Reuters) --  ...

Hong Kong mortuaries hit capacity

 -- Facilities for storing dead bodies at hospitals and public mortuaries in Hong Kong are at maximum capacity due to a record number of COVID-19 fatalities, the Hospital Authority said on Monday, as officials battle to control a surge in cases.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Merck's COVID-19 pill to be produced by drugmakers in 11 additional countries

 

Merck's COVID-19 pill to be produced by more than two dozen drugmakers

Medicines Patent Pool, an organization supported by the U.N., announced on Thursday that over two dozen generic drug makers will soon begin producing Merck's COVID-19 pill to make the treatment more accessible in developing countries.

The organization said that 27 generic drug makers would produce the pill for 105 developing countries. Specifically, agreements the companies signed allow them to make both molnupiravir's raw ingredients as well as the final product.

Molnupiravir is the COVID-19 treatment developed by Merck and Ridgeback Therapeutics. For patients with early signs of COVID-19, the pill is believed to cut the hospitalization rates in half.

Problem, Solution, SitRep, or ?: 

Pages

howdy folks